Found 16 matching trials
Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects PHASE1 To investigate safety, tolerability, pharmacokinetics, pharmacodynamics and...
Show More Location
Fukuoka Clinical Site
Learn More & Join Trial
Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects PHASE1 The purpose of this study is to evaluate the safety and tolerability, pharm...
Show More Location
California Clinical Trials Medical Group
Learn More & Join Trial
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) PHASE2 The main purpose of this study is to determine whether adding SurVaxM to st...
Show More Location
University of California
Learn More & Join Trial
Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma PHASE3 RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells ...
Show More Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Learn More & Join Trial
Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104 PHASE1 First-in-human, phase I, randomized, double-blind, placebo-controlled, sing...
Show More Learn More & Join Trial
Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD PHASE2 Alzheimer's disease (AD) is the most common type of dementia, accounting fo...
Show More Location
Hôpital François Mitterrand
Learn More & Join Trial
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation PHASE2 Phase 2 study, conducted in patients with Hodgkin's disease, non-Hodgkin's ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects PHASE1 A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending D...
Show More Location
CTI Clinical Research Center
Learn More & Join Trial
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease PHASE1 This first-time-in-man study is mainly designed to assess the safety and to...
Show More Location
Univeristätsklinik für Neurologie, PMU, Christian-Doppler Klinik
Learn More & Join Trial
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery PHASE1 RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in differ...
Show More Location
Duke University Medical Center
Learn More & Join Trial